BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
 | 
Oct 19, 2009
 |  BC Week In Review  |  Clinical News  |  Regulatory

Xerclear regulatory update

Medivir said EMEA approved Xerclear in 14 European countries to treat early signs and symptoms of recurrent herpes labialis (cold sores) to reduce the progression...

Read the full 104 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >